Jonathan Levin to Middle Aged
This is a "connection" page, showing publications Jonathan Levin has written about Middle Aged.
Connection Strength
0,855
-
Difference in HIV prevalence by testing venue: results from population level survey in Uganda. AIDS Care. 2021 03; 33(3):273-284.
Score: 0,096
-
Health-care utilization and associated factors in Gauteng province, South Africa. Glob Health Action. 2017; 10(1):1305765.
Score: 0,077
-
The impact of age on the epidemiology of incomplete abortions in South Africa after legislative change. BJOG. 2005 Mar; 112(3):355-9.
Score: 0,034
-
Effect of suicidality on clinical and behavioural outcomes in HIV positive adults in Uganda. PLoS One. 2021; 16(8):e0254830.
Score: 0,027
-
Model-based small area estimation methods and precise district-level HIV prevalence estimates in Uganda. PLoS One. 2021; 16(8):e0253375.
Score: 0,027
-
Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens. Sci Rep. 2020 08 31; 10(1):14324.
Score: 0,025
-
Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy. J Infect Dis. 2020 07 06; 222(3):381-390.
Score: 0,025
-
Decision space and participation of primary healthcare facility managers in the Ideal Clinic Realisation and Maintenance programme in two South African provinces. Health Policy Plan. 2020 Apr 01; 35(3):302-312.
Score: 0,024
-
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial. PLoS One. 2018; 13(12):e0206907.
Score: 0,022
-
Compassion satisfaction, burnout and secondary traumatic stress among termination of pregnancy providers in two South African provinces. J Obstet Gynaecol Res. 2018 Jul; 44(7):1202-1210.
Score: 0,021
-
Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011. Pan Afr Med J. 2018; 29:191.
Score: 0,021
-
Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda. BMC Immunol. 2018 01 03; 19(1):1.
Score: 0,021
-
Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses. PLoS One. 2017; 12(11):e0188396.
Score: 0,021
-
The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study. BMC Palliat Care. 2017 Jul 13; 17(1):8.
Score: 0,020
-
Incidence and Persistence of Major Depressive Disorder Among People Living with HIV in Uganda. AIDS Behav. 2017 Jun; 21(6):1641-1654.
Score: 0,020
-
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort. AIDS Res Ther. 2017; 14:26.
Score: 0,020
-
Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda. Reprod Health. 2017 Mar 11; 14(1):36.
Score: 0,020
-
Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord. 2017 Apr 01; 212:117-127.
Score: 0,019
-
Voluntary medical male circumcision for HIV prevention in fishing communities in Uganda: the influence of local beliefs and practice. Afr J AIDS Res. 2016 Sep; 15(3):211-8.
Score: 0,019
-
Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study. Malar J. 2016 07 15; 15:361.
Score: 0,019
-
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study. AIDS. 2016 Feb 20; 30(4):635-44.
Score: 0,018
-
Factors associated with dropout in a long term observational cohort of fishing communities around lake Victoria, Uganda. BMC Res Notes. 2015 Dec 24; 8:815.
Score: 0,018
-
Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):237-46.
Score: 0,018
-
High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015 May 29; 13:126.
Score: 0,017
-
Hope: a new approach to understanding structural factors in HIV acquisition. Glob Public Health. 2015; 10(4):417-37.
Score: 0,017
-
Effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials. PLoS One. 2014; 9(8):e105089.
Score: 0,016
-
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4? cell counts: findings from a cluster-randomized trial. AIDS. 2014 Feb 20; 28(4):569-76.
Score: 0,016
-
Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART. BMC Infect Dis. 2013 Aug 27; 13:395.
Score: 0,015
-
Contribution of population factors to estimation of human immunodeficiency virus prevalence trends: a cohort study in rural Uganda, 1989-2007. Am J Epidemiol. 2011 Nov 15; 174(10):1175-82.
Score: 0,013
-
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis. 2011 Dec; 11(12):933-41.
Score: 0,013
-
Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda. PLoS One. 2011; 6(6):e20684.
Score: 0,013
-
Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008). Trop Med Int Health. 2011 Jun; 16(6):756-65.
Score: 0,013
-
Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010 Nov; 15(11):1347-56.
Score: 0,013
-
Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):245-52.
Score: 0,013
-
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010 Apr 01; 53(4):496-9.
Score: 0,012
-
Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials. Trop Med Int Health. 2010 Jan; 15(1):105-12.
Score: 0,012
-
Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health. 2009 Feb; 14(2):196-203.
Score: 0,011
-
Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experience. S Afr Med J. 2008 Oct; 98(10):795-800.
Score: 0,011
-
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008 Aug 01; 48(4):468-75.
Score: 0,011
-
Risk factors for domestic violence: findings from a South African cross-sectional study. Soc Sci Med. 2002 Nov; 55(9):1603-17.
Score: 0,007